DUBLIN--(BUSINESS WIRE)--The "Cystinosis Forecast in 19 Major Markets 2017-2027" report has been added to Research and Markets' offering.
Cystinosis is a rare inherited lysosomal storage disorder caused by mutations in the CTNS gene that encodes cystinosin, a lysosomal cystine-proton co-transporter. This results in an abnormal accumulation of the amino acid cystine within the lysosomes of all body cells and tissues. Although it is a monogenic, autosomal recessive disease, there are three clinical presentations of cystinosis based on the age at diagnosis and the magnitude of cellular cystine deposition.
This report provides the current prevalent population for cystinosis across 19 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Austria, The Netherlands, Ireland, Turkey, Japan, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team, the three clinical presentations of cystinosis have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Key Topics Covered:
2. Cause of the Disease
3. Risk Factors & Prevention
4. Diagnosis of the Disease
5. Variation by Geography/Ethnicity
6. Disease Prognosis & Clinical Course
7. Key Comorbid Conditions / Features Associated With the Disease
8. Methodology for Quantification of Patient Numbers
9. Top-Line Prevalence for Cystinosis
10. Types of Cystinosis in Patients
11. Abbreviations Used in the Report
12. Other Publications
13. Patient-Based Databases
14. Patient-Based Offering
15. Online Pricing Data & Platforms
For more information about this report visit https://www.researchandmarkets.com/research/nvb3h5/cystinosis